Heterogeneity in cardiorenal protection by Sodium glucose cotransporter 2 inhibitors in heart failure across the ejection fraction strata: Systematic review and meta-analysis

doi:10.5527/wjn.v12.i5.182

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2296)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-7) series, Tables (1-1) series.

Item

Count

PDF

WORD

HTML

1009

Figures (1-7)

172

Tables (1-1)

188

Sum=1428

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

112

Download

373

Sum=485

Publishing Process of This Article

Item

Count

Browse

Download

242

Sum=324

Dec 25, 2023 (publication date) through Nov 2, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Nephrology

ISSN

2220-6124

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

World J Nephrol. Dec 25, 2023; 12(5): 182-200
Published online Dec 25, 2023. doi: 10.5527/wjn.v12.i5.182

Full Size Figure Download Figure

Figure 3 Meta-analysis of the effects of Sodium glucose cotransporter 2 inhibitors on the all-cause mortality across the heart failure subtypes. HF: Heart failure; HFpEF: Heart failure with preserved ejection fraction; HFrEF: Heart failure with reduced ejection fraction; nos: Not otherwise specified. ^aper 1000 person-years.

Citation: Taheri S. Heterogeneity in cardiorenal protection by Sodium glucose cotransporter 2 inhibitors in heart failure across the ejection fraction strata: Systematic review and meta-analysis. World J Nephrol 2023; 12(5): 182-200
URL: https://www.wjgnet.com/2220-6124/full/v12/i5/182.htm
DOI: https://dx.doi.org/10.5527/wjn.v12.i5.182